Michael Roche
Impact in
- Virology top 0.5%
- HIV Research and Treatment
- Infectious Diseases top 10%
- HIV/AIDS drug development and treatment
- HIV/AIDS Research and Interventions
Papers in
- Virology 46
- HIV Research and Treatment 46
-
- HIV/AIDS drug development and treatment 8
- SARS-CoV-2 detection and testing 1
- Co-authors
- Melissa J. Churchill (35 shared papers)Paul R. Gorry (31 shared papers)Lachlan R. Gray (14 shared papers)Anne M. Ellett (16 shared papers)Steve L Wesselingh (9 shared papers)Sharon R. Lewin (27 shared papers)Jacqueline K. Flynn (11 shared papers)Jasminka Sterjovski (14 shared papers)
- Journals
- Retrovirology (7 papers)Journal of Virology (4 papers)Viruses (4 papers)Virology (4 papers)EBioMedicine (4 papers)
- Partner nations
- AustraliaUnited StatesDenmark
In The Last Decade
Michael Roche
54 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 79
- Virology 1.1k
- Infectious Diseases 210
- Neurology 43
- Oncology 84
- Endocrine and Autonomic Systems 19
Countries citing papers authored by Michael Roche
This map shows the geographic impact of Michael Roche's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Roche with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Roche more than expected).
Fields of papers citing papers by Michael Roche
This network shows the impact of papers produced by Michael Roche. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Roche. The network helps show where Michael Roche may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Roche, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 55 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 101 | |
| 2 | 2022 | 79 | |
| 3 | 2007 | 78 | |
| 4 | 2011 | 70 | |
| 5 | 2020 | 64 | |
| 6 | 2007 | 62 | |
| 7 | 2022 | 58 | |
| 8 | 2013 | 57 | |
| 9 | 2014 | 56 | |
| 10 | 2010 | 53 | |
| 11 | 2016 | 52 | |
| 12 | 2009 | 51 | |
| 13 | 2013 | 47 | |
| 14 | 2021 | 46 | |
| 15 | 2013 | 45 | |
| 16 | 2019 | 39 | |
| 17 | 2011 | 35 | |
| 18 | 2012 | 34 | |
| 19 | 2015 | 34 | |
| 20 | 2021 | 33 |
About Michael Roche
Michael Roche is a scholar working on Virology, Infectious Diseases, Biomaterials, Radiology, Nuclear Medicine and Imaging and Oncology, having authored 55 papers that have together received 1.6k indexed citations. Recurring topics across this work include HIV Research and Treatment (46 papers), HIV/AIDS drug development and treatment (8 papers), SARS-CoV-2 detection and testing (1 paper), Monoclonal and Polyclonal Antibodies Research (1 paper), Virus-based gene therapy research (1 paper), Chemical Synthesis and Analysis (1 paper), Nanoparticle-Based Drug Delivery (1 paper) and Hepatitis B Virus Studies (1 paper). The work is most often cited by research in Virology (1.1k citations), Infectious Diseases (210 citations), Neurology (43 citations), Oncology (84 citations) and Endocrine and Autonomic Systems (19 citations). Michael Roche has collaborated with scholars based in Australia, United States and Denmark. Frequent co-authors include Melissa J. Churchill, Paul R. Gorry, Lachlan R. Gray, Anne M. Ellett, Steve L Wesselingh, Sharon R. Lewin, Jacqueline K. Flynn, Jasminka Sterjovski, Matthew J. Gartner and Anthony Lawrence Cunningham. Their work appears in journals such as Retrovirology, Journal of Virology, Viruses, Virology and EBioMedicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.